We corroborated previously reported FH mutations in nine out of the 18 HLRCC-associated UL cases and identified two missense mutations in FH in only two nonsyndromic UL cases and one control. This evidence concerns the gene FH and hereditary leiomyomatosis and renal cell cancer.